r SCN5a mutations may express gain-of-function (Long QT Syndrome-3), loss-of-function (Brugada Syndrome 1) or both (mixed syndromes), depending on the mutation and environmental triggers. One such trigger may be an increase in cytosolic calcium, accompanying exercise.
Introduction
Inherited arrhythmias may arise from mutations in the the gene for SCN5a, which encodes the cardiac voltage-gated sodium channel (Na V 1.5) (Jones et al. 2011; Priori et al. 2013) . These mutations result in gain-of-function (Long QT Syndrome; LQT3) or loss-of-function (Brugada Syndrome; BrS1) in Na V 1.5. Although BrS1 and LQT3 are clinically distinct, a subset of mutations simultaneously trigger both syndromes (BrS1/LQT3, mixed syndromes) (Rivolta et al. 2001; Clancy & Rudy, 2002; Makita et al. 2008) .
BrS1 and LQT3 patients have differential expressivities depending on the physiological triggers, such as exercise (Shimizu & Antzelevitch, 2000; Veldkamp et al. 2000; Schwartz et al. 2001; Masrur et al. 2015) . BrS1 patients manifest the diagnostic ST-elevation during both exercise and recovery from exercise (Amin et al. 2009; Masrur et al. 2015) . By contrast, LQT phenotype manifestation during exercise is genotype-dependent (Schwartz et al. 2001) . LQT1 patients have cardiac events during exercise, whereas LQT3 is mainly associated with arrhythmia during sleep (Schwartz et al. 1995; Shimizu & Antzelevitch, 2000) . Although sleep is primarily a restful physiological state, the rapid eye movement phase includes exercise-like physiological properties (Somers et al. 1993) . A small proportion of LQT3 patients have lethal cardiac events during exercise (Schwartz et al. 1995) .
Studies showing exercise-induced QT C shortening in LQT3 patients have focused on cases positive for the KPQ mutation (Schwartz et al. 1995; Chandra et al. 1998) . In KPQ patients, the exercise-induced QT C shortening was linked to reductions in late sodium current (late I Na ) caused by elevated cytosolic calcium (Potet et al. 2015) . The assumption that the LQT3 phenotype is rescued by exercise is highly controversial because SCN5a mutation responses to exercise-induced triggers vary (Chen et al. 2015; Abdelsayed et al. 2015) . For example, the C-terminal mutant, E1784K, has greater channel availability with elevated temperature and stimulation frequencies (Abdelsayed et al. 2015) , both of which are associated with exercise. E1784K carriers generally have a high phenotypic gain-of-function (LQT3) expressivity, as in the Okinawa islands, where the mutation is most prevalent, whereas a minority of patients display sinus node dysfunction, BrS1 or mixed syndrome phenotypes (Makita et al. 2008; Takahashi et al. 2014) . Another C-terminal mutant, V2016M, expresses protein kinase-induced gainand loss-of-function translating to epinephrine-induced LQT3 and sinus node dysfunction (Chen et al. 2015) . Unfortunately, little is known regarding the response of SCN5a mutations to physiological factors accompanying exercise. To better understand the variability in response to exercise among SCN5a-mutation patients, it is critical to study Na V 1.5 mutants with cellular perturbations that mimic exercise.
With elevated heart rates, a rise in sympathetic tone triggers multiple cellular cascades that elevate cytosolic calcium (Song et al. 2001; Baartscheer et al. 2003) . The Na V 1.5 C-terminus contains a pair of EF-hand domains and an IQ motif (Kim et al. 2004) . Calcium effects are mediated via calmodulin (CaM) binding to the IQ motif (Chagot et al. 2009; Miloushev et al. 2009; Van Petegem et al. 2012) . The Ca 2+ -CaM complex interacts with the Domain III-IV linker, destabilizing inactivation and increasing Na V 1.5 channel availability during elevated heart rates (Shah et al. 2006) . The presence of intact intra-and inter-C-terminal interactions is essential for calcium binding (Shah et al. 2006) . We hypothesized that mixed syndrome mutants located in intracellular linkers or the C-terminus may either strengthen or weaken the Ca 2+ -CaM modulation of Na V 1.5. Thus, elevated cytosolic calcium may alleviate or exacerbate gain/loss-of-function properties in mutants, consequently rescuing or unmasking the phenotype. The BrS1/LQT3 mutants that we investigated include the Domain III-IV linker mutant, KPQ, and C-terminal mutants, E1784K, 1795insD and Q1909R. All of these mutants are located in calcium-sensitive regions known to modulate Na V 1.5 fast and slow inactivation.
Methods

Ethical approval
The research was approved by Biohazards review 251-2012 issued by the office of the Environmental Health and Safety at Simon Fraser University, Burnaby, BC, Canada.
Cell culture and transfection
Human embryonic kidneys 293 (HEK293) cells were grown at pH 7.4 in a DMEM (1 ×) nutrient medium (Life Technologies, Grand Island, NY, USA), supplemented with 10% fetal bovine serum and maintained in a humidified environment at 37°C with 5% CO 2 . To preserve Ca 2+ -CaM effects on Na V 1.5, HEK293 cells were selected for the present study because they contain a relatively high [CaM] free level compared to other cell lines (Black et al. 2004) .
Transfection followed the procedures suggested by the manufacturer (Qiagen, Valancia, CA, USA). Briefly, 1.5 μg of the Na V 1.5 α subunit, 0.75 μg of the sodium channel β 1 subunit and 1.5 μg of enhanced green fluorescent protein were allowed to incubate with 15 μl of polyfect transfection reagent (Qiagen) and 146 μl of unsupplemented medium for 10 min. The cDNA mixture was then allowed to incubate with the HEK293 cells for 8 h before plating on coverslips.
Electrophysiology
Whole-cell patch clamp recordings were performed in extracellular solution containing (mM): 96 NaCl, 4 KCl, 2 CaCl 2 , 1 MgCl 2 and 10 Hepes (pH 7.4). Solutions were titrated with CsOH. Pipettes were fabricated with a P-1000 puller using borosilicate glass (Sutter Instruments, Novato, CA, USA), dipped in dental wax to reduce capacitance, then thermally polished to a resistance of 1.0-1.5 M . Voltage measurement error were minimized by using low resistance electrodes to limit series resistance between pipette and intracellular solution to 3.5 M or less. Pipettes were filled with intracellular solution. For minimal cytosolic calcium levels, reported below as 0 nM, pipettes contained (mM): 130 CsF, 9.6 NaCl, 10 Hepes and 10 EGTA titrated to pH 7.4. To mimic average and peak systolic cytosolic calcium, we calculated, using the Ca-EGTA Calculator TS, version 1.3 (http://maxchelator.stanford.edu), the amount of CaCl 2 added to bring cytosolic calcium to 500 and 2500 nM: 8.04 and 9.5 mM CaCl 2 , respectively (Steenbergen et al. 1987; Kirschenlohr et al. 2000) .
All recordings were made using an EPC-9 patch clamp amplifier (HEKA Elektronik, Lambrecht, Germany) digitized at 20 kHz using an ITC-16 interface (HEKA Elektronik). Data were acquired and low-pass-filtered (5 kHz) using PatchMaster/FitMaster software (HEKA Elektronik) running on an Apple iMac (Apple Computer, Cupertino, CA, USA). Leak subtraction was performed online using a P/4 procedure. Recordings were performed at room temperature (22°C). After a giga ohm resistance seal was achieved, the whole-cell configuration was attained. The holding potential between protocols was −110 mV. We recorded I Na from cells that expressed currents no greater than -5 nA. The average voltage error calculated for all cells used in this study (n = 362) is 5.16 ± 0.24 mV (Table 1) . There are no differences between the voltage-errors in the different conditions (P > 0.05).
TTX-subtraction experiments
To confirm the mutant-induced increases in late I Na , we performed TTX-subtraction experiments at 0 nM cytosolic calcium, where the late I Na in mutant channels was the largest. The concentration of TTX used was 40 μM in extracellular solution. The 40 μM TTX current trace was subtracted from the control (non-TTX) current trace in all conditions to calculate the TTX-sensitive late I Na .
Analysis and statistics
Analysis and graphing were done using FitMaster software (HEKA Elektronik) and Igor Pro (Wavemetrics, Lake Oswego, OR, USA) with statistical information derived using JMP statistical software (SAS Institute Inc., Cary, NC, USA). Statistical significance was accepted at P < 0.05 using a two-factor completely randomized design ANOVA test followed by a post hoc Tukey test. Statistical results were obtained for the channel variant, calcium, and channel variant × calcium factors. We report the statistical results for the mutants and the interaction between mutants and calcium. All values reported are given as the mean ± SEM.
M. Abdelsayed and others J Physiol 595.18 Voltage protocols Peak sodium current density (I Na ). We measured current density from the ratio of peak current amplitude in pA to the cell membrane capacitance in pF.
Maximal peak and late sodium conductance density (G Na ). Maximal conductance density relates to membrane channel trafficking and expression. We could not directly measure maximal peak or late conductance density, rather we indirectly calculated it from the conductance at 0 mV, measured by a test pulse described with respect to conductance (GV) (see below):
where G Na is the conductance at 0 mV, g Na is the conductance at 0 mV (calculated using eqn (2)) and C M is the membrane capacitance (pF).
Conductance (GV).
To determine the voltage dependence of activation, we measured the peak current amplitude at test pulse potentials ranging from −100 mV to +80 mV in increments of +10 mV for 19 ms. Prior to the test pulse, channels were allowed to recover from fast inactivation at −130 mV for 197 ms. Channel conductance was calculated from peak I Na .
where g Na is sodium channel conductance, I Na is peak sodium current in response to the command potential V, and E rev is the reversal potential. Calculated values for conductance were fit with the Boltzmann function:
where G/G max is the normalized conductance amplitude, V m is the command potential, z is the apparent valence, e 0 is the elementary charge, V 1/2 is the midpoint voltage, k is the Boltzmann constant and T is temperature (K).
Steady-state fast inactivation (SSFI).
The voltage-dependence of SSFI was measured by preconditioning the channels to a hyperpolarizing potential of −130 mV and then eliciting prepulses between −150 mV and +10 mV in increments of 10 mV for 500 ms. Channel availability was assessed during a test pulse to 0 mV. Different hyperpolarizing prepulse potentials (−130 mV or −150 mV) were used to obtain a plateau for the SSFI curve. Normalized current amplitude as a function of voltage was fit using the Boltzmann function: (4) where I/I max is the normalized current amplitude, z is apparent valence, e 0 is the elementary charge, V m is the prepulse potential, V 1/2 is the midpoint voltage of SSFI, k is the Boltzmann constant and T is temperature (K).
Fast inactivation onset.
Time constants for open-state fast inactivation were derived by fitting a double exponential function to the decay of current obtained from the activation protocol. To measure closed-state fast inactivation onset, channels were preconditioned at −130 mV prior to a prepulse at −50 mV, −70 mV or −90 mV for 0 -0.256 s. Current amplitude was measured during a test pulse to 0 mV for 20 ms. Normalized current amplitudes as a function of time were fit using a double exponential equation:
where I is current amplitude, I ss is the plateau amplitude, α 1 and α 2 are the amplitudes at time 0 for time constants τ 1 and τ 2 , and t is time.
Fast inactivation recovery. Channels were fastinactivated during a 500 ms depolarizing step to 0 mV. Recovery was measured during a 19 ms test pulse to 0 mV following 0-1.024 s conditioning pulses at −130 mV, −110 mV or −90 mV. Time constants of fast inactivation recovery as a function of time were fit using a double exponential equation, as above.
Persistent current. Persistent current was measured between 450 and 500 ms during a 500 ms depolarizing pulse to 0 mV from a holding potential of -130 mV. An average of 30 pulses was used to increase the signal-to-noise ratio.
Steady-state slow inactivation (SSSI).
The voltage-dependence of SSSI was measured by preconditioning the channels to −150 mV for 30 s and then eliciting prepulse potentials that range from −150 to −10 mV in increments of 20 mV for 60 s. Channel availability was assessed during a test pulse to 0 mV following a −130 mV recovery pulse from fast inactivation at 20 ms. Normalized current amplitude as a function of voltage was fit using a modified Boltzmann function:
where I 1 and I 2 are maximum and minimum values of fit. The other symbols are as defined previously.
Slow inactivation onset. To measure onset into slow inactivation, channels were preconditioned at −130 mV for 30 s prior to a prepulse at 0 mV for 0-64 s. A test pulse to 0 mV followed a −130 mV fast inactivation recovery pulse for 20 ms. Normalized current amplitude as a function of time was fit with a double exponential.
Slow inactivation recovery. To measure recovery from slow inactivation, channels were preconditioned at −130 mV for 30 s prior to a prepulse at 0 mV for 60 s, followed by series of test pulses to 0 mV for 20 ms between increasing incremental recovery durations at −130 mV for 0 -32s. Normalized current amplitudes as a function of time were fit using a double exponential equation with the plateau equal to 1.00.
Weighted slow inactivation time constants. The weighted slow inactivation time constant at each voltage was calculated using the double τ values obtained from eqn (5):
Slow inactivation α j and β j rates
The recovery from slow inactivation (forward, α j ) and the onset into slow inactivation (reverse, β j ) rates were calculated using Hodgkin-Huxley formulations:
where j Ý is channel availability obtained from eqn (6) and τ j is the weighted slow inactivation time constant obtained from eqn (7), at a given voltage. The slow inactivation α j rates vs. voltage were fit using a single exponential curve and β rates were fit with a line with a slope of 0.
Myocardial action potential (AP) modelling
APs were simulated using a modified version of the O'Hara Rudy (ORd) model at 37°C programmed in Python (O'Hara et al. 2011) . The sodium data were extrapolated to physiological temperatures using previously reported Q 10 values for WT, KPQ and E1784K variants (Nagatomo et al. 1998; Abdelsayed et al. 2015) . The thermosensitivity of 1795insD and Q1909R mutants was never reported; thus, we used the WT temperature-dependence for these mutants. The maximal G Na density was 75 mS μF −1 across all channel variants in the ORd model. We modified the gating I Na parameters data in accordance with our biophysical data for the various channel variants. The GV, SSFI and SSSI midpoints and slopes of the channel variants extrapolated to 37°C were normalized to the original ORd parameters. The normalized midpoint and slope values for GV and SSFI were then incorporated into the Boltzmann curve (eqn (4)) and SSSI into the modified Boltzmann curve (eqn (6)). The original ORd SSSI (j Ý ) curve was equated to the SSFI curve (h Ý ), which had no plateau. Our experimental SSSI plateaus were subtracted from the original ORd value of 0 to compensate for this caveat. The phosphorylated steady-state fast inactivation midpoints in all channel variants were equally hyperpolarized by 6.2 mV. Late I Na density was normalized to the original ORd value and multiplied by the percentage of late to peak I Na calculated above. The relationship between fast inactivation time constants vs. voltage was calculated using an inverse double exponential distribution at 37°C. The ORd slow inactivation time constant equation was used for all the channel variants since it encompassed a comprehensive range of voltages.
To model the calcium-dependence of our I Na data, we fit the extrapolated biophysical parameters to 37°C with a Hill equation:
where Z is the biophysical parameter of interest, Y 0 is the minimum value, Y M is the maximum value, X 1/2 is the midpoint of the curve, X is the intracellular cytosolic calcium and b is the rate.
Subspace calcium was not accounted for as a result of the lack of experimental data. Thus, the modified ORd model is a dynamic simulation of the calcium-induced shifts that are observed with increasing intracellular calcium levels as a function of pacing frequency, comprising the positive staircase phenomenon.
Simulations were run on endocardial and epicardial ventricular myocytes using a 0.5 ms stimulus pulse with an amplitude of −80 μA μF −1 . The stimulus protocol was designed accordingly to step up the frequency gradually from 0.5 Hz to 2.5 Hz. The stimulus protocol had a cycle length of 2000 ms for the first 75 APs, 1000 ms for the following 75 APs, 667 ms for the following 75 APs, 500 ms for the following 75 APs and 400 ms for the following 100 APs.
Analysis of APs only included those that fully recovered and were restored to baseline. Action potential duration (APD) was measured at 30%, 60% and 90% of repolarization by multiplying these percentages by the resting membrane potential (RMP) value prior to the current stimulus pulse. The APD X (X = 30, 60, 90) values were plotted vs. the diastolic interval (DI = BCL -APD X ), where BCL is the basic cycle length, creating electrical restitution curves. The curves were fitted with a double-exponential eqn (5). AP velocity was calculated from initiation of the current stimulus to the maximal peak.
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Results
Peak current amplitude and conductance density
Raw I Na traces are shown in Fig. 1 for all the channel variants at 0 and 2500 nM. The current density of 1795insD was smaller (P < 0.0001) (Table 2) compared to WT and the rest of the mutants. Elevations in cytosolic calcium had no effect on current density in any of the channel variants (P > 0.05) (Fig. 1A) (Table 2 ). Peak conductance density was also reduced in 1795insD compared to WT and the mutants (P < 0.0001) (Fig. 1B and Table 2 ). In KPQ, peak conductance density was larger (P = 0.0158) ( Table 2) by 4.81 ± 1.24 pA/pF when cytosolic calcium was elevated from 0 to 2500 nM. No other mutants were affected by elevations in cytosolic calcium (P > 0.05) ( Table 2) .
Activation voltage-dependence
Normalized conductance is plotted as a function of membrane potential in Fig. 2 . Activation midpoint (GV-V 1/2 ) was depolarized in all mutants compared to WT (P < 0.0001) ( Table 3 ). The mutants depolarized GV-V 1/2 in an increasing order compared to WT: Q1909R, 1795insD, E1784K and KPQ, respectively. In all channel Q1909R 0 nM 500 nM 500 nM 500 nM 500 nM 2500 nM 2500 nM 2500 nM 2500 nM 0 nM 0 nM 0 nM 500 nM 2500 nM 0 nM 0 nM 500 nM 500 nM 500 nM 500 nM 2500 nM 2500 nM 2500 nM 2500 nM 0 nM 0 nM 0 nM 500 nM 2500 nM 0 nM 0 nM 500 nM 500 nM 500 nM 500 nM 2500 nM 2500 nM 2500 nM 2500 nM 0 nM 0 nM 0 nM 500 nM 2500 nM 0 nM 0 1795insD
Figure 1. Current traces and properties
Raw current traces for the wild-type and mutant channels at 0 and 2500 nM cytosolic calcium. A-C, peak I Na current density, peak I Na conductance density and late I Na conductance density, respectively, as a function of the three cytosolic calcium levels. The asterisk in (B) indicates a rise in KPQ conductance density with elevations in cytosolic calcium from 500 to 2500 nM. [Colour figure can be viewed at wileyonlinelibrary.com] variants, GV-V 1/2 was not affected by elevations in cytosolic calcium (P > 0.05) ( Table 3) . Activation slope (GV-z) was reduced in the same order as the mutant-induced GV-V 1/2 shifts (P < 0.0001) ( Table 3) . Elevations in cytosolic calcium did not affect GV-z in any channel variant (P > 0.05) ( Table 3) .
Fast and intermediate inactivation voltage-dependence
Normalized current vs. membrane potential is shown in Fig. 3 . The steady-state fast inactivation midpoint (SSFI-V 1/2 ) was hyperpolarized by KPQ, E1784K and 1795insD compared to WT (P < 0.0001) ( Table 4 ). The SSFI-V 1/2 of KPQ was depolarized (P < 0.0001) by elevations in cytosolic calcium compared to the other channel variants (P > 0.05) (Table 4 ). When cytosolic calcium was elevated from 0 to 500 nM, the SSFI-V 1/2 of KPQ depolarized by 8.03 ± 1.82 mV (P < 0.0001) (Table 4) . Additional elevations in cytosolic calcium to 2500 nM did not further depolarize the SSFI-V 1/2 of KPQ (P > 0.05) ( Fig. 3C and Table 4 ). The steady-state fast inactivation slope (SSFI-z) was reduced in E1784K, 1795insD and Q1909R compared to WT J Physiol 595.18
(P = 0.0021) ( Table 4) . Elevations in cytosolic calcium had no effects on SSFI-z in any channel variant (P > 0.05) ( Table 4) . Steady-state intermediate inactivation (SSII) was measured using a similar protocol to SSFI, except with 1000 ms prepulse durations (Table 4) . The SSII-V 1/2 of E1784K and 1795insD are hyperpolarized compared to WT (P < 0.0001) ( Table 4 ). Both mutants also reduced SSII-z (P < 0.0001) (Table 4 ) compared to WT. Elevations in cytosolic calcium had no effect on both SSII-V 1/2 and SSII-z in any channel variant (P > 0.05) ( Table 4) .
Fast inactivation recovery and onset kinetics
Double-pulse protocols were used to measure onset (τ on ) and recovery (τ off ) kinetics of fast inactivation. The time constant (τ) obtained from the fits to the recovery and onset curves equals the inverse of the sum of both the forward (recovery) and reverse (onset) rates. At voltages hyperpolarized relative to SSFI-V 1/2 , recovery from fast inactivation predominates. At voltages depolarized relative to SSFI-V 1/2 , onset into fast inactivation predominates. At SSFI-V 1/2 , both onset and recovery are in equilibrium. Fast inactivation time constants as a function of voltage are reported in Tables 5 and 6 . At −10 mV, the fast time constant (τ 2 ) KPQ decreased when cytosolic calcium was elevated from 0 to 500 nM. 1795insD slow time constant (τ 2 ) is increased at −30 mV when cytosolic calcium was elevated from 500 to 2500 nM. Q1909R fast inactivation kinetics were decelerated at both open-state and closed-state voltages with elevations in cytosolic calcium. 
Late current amplitude and conductance density
Late I Na conductance density was measured similarly to peak conductance density. Elevations in cytosolic calcium had no effect on late conductance density in any of the channel variants (P > 0.05) (Fig. 1C and Table 7) .
Raw I Na current records emphasizing late I Na are shown in Fig. 4A-D . Traces of TTX-sensitive late I Na in all mutants compared to WT are shown in Fig. 4E -H. The current traces were normalized to peak I Na . Late I Na was larger in the mutants compared to WT (P < 0.0001) ( Table 7) . Late I Na was lower by 1.58% ± 0.44% in KPQ and by 1.95% ± 0.44% in 1795insD when cytosolic calcium was elevated from 0 to 2500 nM (P < 0.0001) (Fig. 4I and Table 7 ). In Q1909R, late I Na was lower by 2.36% ± 0.48% when cytosolic calcium was elevated from 0 to 500 nM (P < 0.0001) (Fig. 4I and Table 7 ). Further elevations in cytosolic calcium did not affect late I Na of Q1909R (P > 0.05) ( Table 7) . Late I Na of E1784K was not affected by elevations in cytosolic calcium (P > 0.05) ( Table 7) .
Slow inactivation voltage-dependence
Normalized current vs. membrane potential is shown in Fig. 5 . The steady-state slow inactivation midpoint (SSSI-V 1/2 ) was not different in any of the channel variants (P > 0.05) ( Table 8 ). The SSSI-V 1/2 of E1784K was depolarized by 23.2 ± 5.20 mV when cytosolic calcium was elevated from 500 to 2500 nM (P = 0.0005) (Fig. 5D and Table 8 ). The steady-state slow inactivation slope (SSSI-z) was not affected by the mutants (P > 0.05) ( Table 8 ). SSSI-z of 1795insD was larger by 0.79 ± 0.18 when cytosolic calcium was elevated from 500 to 2500 nM (P = 0.0035) ( Table 8 ). The steady-state slow inactivation plateau (SSSI-Y 0 ) was higher in E1784K by 21.7% ± 5.3% when cytosolic calcium was elevated from 0 to 2500 nM (P < 0.0001) ( Fig. 5D and Table 8 ). The SSSI-Y 0 of Q1909R was higher by 18.0% ± 0.05% when cytosolic calcium was elevated from 500 to 2500 nM (P < 0.0001) ( Fig. 5F and Table 8 ).
Slow inactivation recovery and onset kinetics
The weighted slow inactivation time constants are plotted as a function of the membrane potential in Fig. 6A and B. Slow inactivation recovery (α) rates are plotted against voltage in Fig. 6C -F and slow inactivation onset (β) rates in Fig. 6G . Mutant effects on τ are reported in Tables 9 and  10 . At −130 and −110 mV, recovery kinetics of Q1909R are accelerated (P < 0.0001) ( Table 9 ) when cytosolic calcium was elevated from 0 to 500 nM. Slow inactivation recovery kinetics were also accelerated in E1784K at −110 mV (P < 0.0001) ( Table 9 ). The other channel variants had no significant changes in recovery. At voltages greater than −70 mV, slow inactivation kinetics was not affected by elevations in cytosolic calciumin any channel variant (Tables 9 and 10 ).
Ventricular AP simulations
With increasing pacing frequency stimulations, intracellular calcium naturally increases inside the cell, known as the positive staircase phenomenon. To simulate dynamic properties of the experimentally observed calcium-induced I Na shifts, we used a modified version of the ORd model to generate APs in the endocardial and epicardial cells. The I Na gating parameters were held uniform across all the three cell types. The last AP simulated at each frequency is in Fig. 7 for all the channel variants at bradycardia, normal and tachycardia heart rates. In E1784K, AP is lost with every other beat at elevated heart rates. Thus, both the final two E1784K APs at each frequency are shown in Fig. 7 . AP upstroke velocity and APD at 30%, 60% and 90% of repolarization were measured and are shown in Fig. 8 . AP upstroke velocity was substantially reduced in KPQ, E1784K and 1795insD compared to WT and Q1909R ( Fig. 8A and B) . With decreasing BCLs, particularly below 600 ms, the Q1909R upstroke velocities are reduced. AP upstroke velocity in the remaining mutants appeared to be insensitive to any BCL shortening.
APDs (APD X , X = 30,60,90) are plotted vs. the diastolic interval in Fig. 8C to create electrical restitution curves (ERCs). The plateaus of the ERC curves were increased with increasing APD X . The greatest change in ERC as function of repolarization time was evident in E1784K compared to other variants, which displays prolonged APD at reduced diastolic intervals. In addition, the ERC slope is greatest in E1784K (APD 90 ), suggesting greater arrhythmogenicity.
The shifts observed in APD as a function of heart rate in all the mutants can be ascribed to the positive-staircase rise in cytosolic calcium. When the calcium-dependent gating in I Na was disabled (results not shown), APD 90 was less sensitive to higher pacing frequencies, suggesting a calcium-mediated effect on AP morphology in the mutants that were studied.
To further investigate the frequency-dependent shortening of APD, we calculated the difference in APD 90 between successive frequencies shown Fig. 8D . In the endocardial cell, the APD 90 shortening displays a relatively U-type frequency dependence. The inflection point is evident especially at 1.5 Hz. However, E1784K exacerbates the U-type frequency dependence by prolonging greatly (Fig. 8D) . This result suggests a frequency-dependent APD prolongation in E1784K. Each of the mutants characterized in the present study increases the late I Na compared to WT. Increases in intracellular sodium, [Na] i , known as sodium overload, causes the sodium-calcium exchanger (NCX) to function in reverse mode, inducing a calcium-overload, which underlies cardiac diastolic dysfunction. The rise in intracellular calcium ([Ca 2+ ] i ) during the AP time course is shown Fig. 9 (Fig. 9B, inset) (Fig. 9E) 
Discussion
Elevated cytosolic calcium, induced by sympathetic stimulation during exercise, may serve as a potential arrhythmogenic trigger in patients with SCN5a mutations. The present study aimed to explore the response of mixed syndrome mutants to elevated cytosolic calcium. The mutants that were investigated have differential cytosolic calciumsensitivities. We found that biophysical defects were either ameliorated or exacerbated by elevated cytosolic calcium in a mutant-dependent fashion.
Elevated cytosolic calcium clearly attenuates late I Na in KPQ, 1795insD and Q1909R. Because late I Na is a key pathophysiological substrate in LQT3, elevated cytosolic rescues the gain-of-function phenotype in those Na V 1.5 mutants. By contrast, the therapeutic effect of cytosolic calcium is hampered in E1784K, suggesting that carriers may express LQT3 properties under elevated heart rates. Although our experiments were performed at room temperature, we predict that our results, and their phenotypic sequelae, may be exacerbated at higher temperatures because E1784K is also highly thermosensitive (Abdelsayed et al. 2015) . Our AP modelling confirms that the most arrhythmogenic mutant is E1784K and it also predicts a large dispersion of repolarization across the ventricular wall. E1784K was the only mutant that was predicted to cause a [Na + ] i -overload under both bradycardia and tachycardia by our model. The other mutants characterized showed decreases in [Na + ] i with elevated heart rates. The model also predicts [Na + ] i -overload, exacerbating E1784K arrhythmogenicity by driving NCX to run in reverse mode, further increasing cytosolic calcium. Increased cytosolic sodium and calcium results in electrical and mechanical cardiac abnormalities (Antzelevitch et al. 2014) .
Biophysical implications
The Domain III-IV linker and C-terminus are crucial for both fast and slow inactivation in sodium channels. Mutations in these regions perturb their normal interaction both under diastolic calcium levels and upon a calcium signal, causing a defect in Na V 1.5 inactivation. The C-terminus contains indirect binding sites for calcium (Mori et al. 2003; Biswas et al. 2009 ), including a pair of EF-hand domains composed of a helix-loop-helix, from Glu1773 to Asp1852 (comprising helices 1-4, H1-H4) (Wingo et al. 2004; Shah et al. 2006) . Approximately 120 residues downstream, an IQ domain binds to CaM (Cormier et al. 2002; Tan et al. 2002; Wingo et al. 2004) . The influence of calciumon inactivation has been studied using electrophysiology and isothermal titration calorimetry experiments (Shah et al. 2006; Sarhan et al. 2012) . Under low calcium conditions, CaM binds via the C-lobe to the IQ domain of the C-terminus (Chagot et al. 2009 ). When cytosolic calcium levels rise, the CaM N-lobe binds to the IQ domain and the C-lobe binds to the Domain III-IV linker, as in the tripartite complex (Shah et al. 2006; Biswas et al. 2009; Gaudioso et al. 2011; Sarhan et al. 2012) .
Previous studies report intra C-terminal interactions, observed by fluorescence resonance energy transfer. The −76.4 ± 2.88 −1.23 ± 0.09 0.35 ± 0.02 6 * 1 P < 0.01 (V 1/2 ) and P < 0.05 (Y 0 ) vs. E1784K (0 and 500 nM). * 2 P < 0.05 vs. 1795insD (0 nM). * 3 P < 0.05 vs. Q1909R (500 and 2500 nM). IQ motif (H6) in the C-terminus interacts with the aromatic residues of H1 (F1791 and Y1795) and the N-terminal residues of H6 interact with residues in H1-H2 and H2-H3 linkers (Glaaser et al. 2006; Chagot et al. 2009 ). Proximity of the EF-hand domain to the IQ motif is required for proper inactivation (Glaaser et al. 2012) . The intra C-terminal interaction associates with the Domain III-IV linker, modulating inactivation (Bankston et al. 2007) . Studies supporting the tripartite complex show that residues 1498-1501 in the Domain III-IV linker form an α helix that interacts with the C-lobe of CaM, whereas the rest of the residues within the linker (1502-1522) are disordered (Sarhan et al. 2012) . Deletion of residues 1505-1507 in KPQ normally increases late I Na and stabilizes steady-state fast inactivation at RMP (Chandra et al. 1998) . Stabilized inactivation may occur as a result of a tighter association between the truncated III-IV linker and its binding site in the inner vestibule of Na V 1.5. Shortening the Domain III-IV linker in KPQ may increase the affinity for CaM binding upon a calcium signal. This further destabilizes fast inactivation and increases channel availability as is evident in the calcium-induced depolarized shift in SSFI midpoint.
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We predict the charge-reversal in E1784K disrupts crucial electrostatic interactions linking the IQ motif to the EF-hand domain, resulting in an abnormally structured C-terminus. The positive lysine may form electrostatic interactions with downstream negative charges in H1, altering the IQ-EF-hand interaction, and resulting in a loosely bound IQ. Consequently, the IQ-CaM complex may be more mobile and unable to modulate fast inactivation via the Domain III-IV linker because IQ-CaM requires anchorage to H1 (Pitt & Lee, 2016) . Because the IQ-EF-hand interaction is destabilized, calcium affinity might decrease (Shah et al. 2006; Chagot et al. 2009 ). As a result, elevations in cytosolic calcium may be unable to attenuate increases in late I Na in E1784K. The fast inactivation mechanism elicited by Domain III-IV linker is assumed to function in synchrony with the C-terminus, affecting slow inactivation (Motoike, 2004 and thus affect the interaction between fast and slow inactivation. Consequently, the increase in E1784K late I Na with elevations in cytosolic calcium accompanies a destabilized slow inactivation at depolarized potentials Richmond et al. 1998) .
The 1795insD mutant is in the EF-hand domain (H1) adds a negative charge to the region. Chagot et al. (2009) show that Y1795 is a key residue, establishing hydrophobic interactions with the IQ motif. Adding a negative charge may stabilize the EF-hand domain and preserve the intactness of the C-terminal interactions, yielding greater sensitivity by Na V 1.5 to effects of Ca 2+ -CaM. The Q1909R mutation is in the initial segment of the IQ motif, which is the region that CaM associates with via its N-terminus during a calcium signal and via its C-lobe during diastolic calcium. In the IQ motif, Arg3 and Arg6 are bound by hydrogen bonds to different CaM residues. It is thus expected that the Q1909R mutation should enhance CaM binding. Fast inactivation τ onset in both 1795insD and Q1909R was decelerated at depolarized potentials in a calcium-dependent fashion, agreeing with past data showing calcium-induced deceleration of fast inactivation τ onset in WT Na V 1.5 (Biswas et al. 2009 ).
Physiological implications
Accentuated gain-of-function in E1784K by elevated cytosolic calcium increases [Na + ] i -overload. Our ORd model simulations suggested that prolonged APDs are ameliorated by elevated pacing in KPQ, 1795insD and Q1909R. E1784K APD is relatively prolonged, even during tachycardia. Furthermore, in all mutants except E1784K, the [Na + ] i : [Ca 2+ ] i ratio is adjusted or minimized. In E1784K, a discordant curve develops, in which the sodium overload is observed at different heart rates. Sodium overload induces multiple cellular cascades, including the reverse mode in NCX, a factor known to shorten APD at elevated heart rates (Faber & Rudy, 2000; Moreau et al. 2013) . Reverse mode NCX causes a rise in intracellular calcium, which threatens diastolic stability, resulting in diastolic dysfunction. In addition to those mechanical abnormalities, calcium overload disturbs the electrical stability of myocardial tissue by inducing DADs, increasing the likelihood of lethal cardiac events including ventricular tachycardia/fibrillation.
Clinical implications
The effect of exercise on LQT3 remains unsettled and controversial. Schwartz et al. (1995) reported a marked reduction in QT C during exercise in LQT3 patients. This effect is lost during recovery from exercise. Most of the patients in that study carried the KPQ mutation. A reduced QT C in KPQ may be explained by frequency-or calcium-dependent attenuation of late I Na . Nevertheless, a relatively minor percentage of LQT3 patients develop cardiac events during exercise. It remain to be determined whether sleep or rest without arousal (i.e. low heart rates) fully explains arrhythmogenesis in LQT3 because the rapid eye movement phase of sleep is accompanied by high sympathetic tone. Thus, both sleep and exercise share some common physiological properties and may share a mechanism of arrhythmogenesis in some LQT3 cases. These commonalities raise questions about the utility of β-blockers as potential therapeutics for all LQT3 patients, regardless of the causative mutation. The variance seen in BrS1/LQT3 response to exercise depends, at least in part, on the exact SCN5a mutation. Thus, genetic screening is a critical diagnostic tool for determining whether exercise may be therapeutic or an arrhythmogenic trigger in SCN5a patients.
Conclusions
Greater calcium sensitivity in E1784K is reflected by the AP model, in which E1784K prolongs the APD.
Compared to the other mutants, E1784K results in the largest transmural voltage gradient. The results of the present study may lead to further refined treatments for BrS1/LQT3. Anti-arrhythmics, potent for LQT3, should be tested in mixed syndrome cases because the propensity to be phenotypically LQT3 and/or BrS1 may be affected by triggers such as exercise. Cellular cascades, such as activation of the Ca 2+ /CaMKII and other protein kinases, may determine the mutant-specific biophysical effects of arrhythmogenic mutations (Herren et al. 2013) . The present study is probably biased to the effects of calcium on predominantly phosphorylated Na V 1.5 as a result of the use of internal fluoride, which inhibits phosphatases (Proud, 1994) . Future assays should measure phosphorylation-induced shifts on gating and channel expression to further clarify how physiological changes impact the arrhythmogenicity of these mutants. The results of the present study support the need for a more detailed biophysical analysis of all mutants underlying sudden cardiac death.
